Pharmacy Certification · BCPPS

BPS Pediatric Pharmacy Certification Examination Practice Test

Pediatric pharmacy requires adapting medication selection, dosing, and monitoring to a child’s age, weight, development, and clinical condition. The BCPPS practice questions sample calculations using weight-based doses and adult maximums, dose-volume conversions, age-related pharmacokinetics, and medication safety in situations such as renal impairment, infusion incompatibility, and adverse effects.

Exam overview

Exam providerBoard of Pharmacy Specialties
Exam codeBCPPS
CategoryPharmacy Certification

About the BPS Pediatric Pharmacy Certification Examination Exam

Pediatric medication decisions involve more than scaling an adult dose: pharmacists must interpret age- and weight-based regimens, recognize dose ceilings, and account for developmental differences in drug clearance. The question bank also samples safety checks such as assessing renal function when hydration or kidney clearance may affect exposure, reviewing QT-prolongation risks, and identifying clinically important adverse effects. Other scenarios ask learners to prevent administration errors, including avoiding a dangerous route for vincristine and checking compatibility before administering an intravenous medication through a line. These problems connect calculations and pharmacology to practical tasks: verifying prescriptions, identifying information needed before dispensing, monitoring response, and anticipating treatment-related changes, including during diabetic ketoacidosis management.

Sample Practice Questions

Review a selection from this exam's published US Practice Tests practice bank.

Question 1

A child taking valproate develops new bruising and prolonged bleeding from minor cuts. Which medication-related adverse effect should be considered?

  1. AThrombocytopenia or impaired hemostasis
  2. BPermanent tooth discoloration
  3. CAcute hearing loss
  4. DIncreased bone mineral density
Show answerCorrect answer: A

Valproate can be associated with thrombocytopenia and other effects on hemostasis. New bruising or bleeding warrants prompt clinical evaluation and consideration of blood counts and coagulation-related assessment as appropriate.

Question 2

A 9-year-old with acute lymphoblastic leukemia is receiving vincristine. Which route must be avoided because it can cause catastrophic neurotoxicity?

  1. AIntravenous
  2. BIntramuscular
  3. CIntrathecal
  4. DSubcutaneous
Show answerCorrect answer: C

Vincristine must never be administered intrathecally; this route can cause severe, often fatal neurotoxicity. Route-specific safeguards and clear labeling help prevent this error.

Question 3

A 7-year-old weighing 24 kg is prescribed a medication with a usual pediatric dose of 10 mg/kg per dose. The adult maximum is 500 mg per dose. What is the appropriate calculated dose before considering other patient-specific factors?

  1. A120 mg
  2. B240 mg
  3. C500 mg
  4. D2,400 mg
Show answerCorrect answer: B

Multiply the weight-based dose by the child's weight: 10 mg/kg × 24 kg = 240 mg per dose. This is below the stated adult maximum of 500 mg. The prescription should still be checked against indication-specific dosing guidance and other limits.

Question 4

A 3-year-old is prescribed acetaminophen for fever. Which dosing approach is most appropriate when determining the dose?

  1. AUse the child’s current weight and verify the dose against an appropriate pediatric dose range and maximum
  2. BUse the same fixed dose for every child under 12 years
  3. CUse the child’s age alone, regardless of weight
  4. DUse the caregiver’s estimate of the child’s usual dose
Show answerCorrect answer: A

Pediatric medication doses commonly depend on current weight, and the calculated dose should be checked against established dosing limits, including any maximum dose. Age alone or an unverified customary dose may be inaccurate.

Question 5

A 5-year-old with fever and poor oral intake is prescribed an oral medicine that is substantially cleared by the kidneys. Which assessment is especially relevant before and during treatment?

  1. AHydration status and renal function
  2. BHair color and visual acuity
  3. CDietary calcium intake alone
  4. DWhether the child has seasonal allergies
Show answerCorrect answer: A

Dehydration and impaired renal function can reduce renal drug elimination and increase the risk of accumulation for medicines cleared substantially by the kidneys. Clinical status and relevant renal measures should inform treatment and monitoring.

Question 6

A child with a central venous catheter is prescribed an intravenous medication that is incompatible with the current infusion. Which approach is most appropriate before administration?

  1. AUse a separate compatible lumen or follow an approved pause-and-flush procedure
  2. BMix both medicines in the same bag to reduce line use
  3. CIncrease the infusion rate so contact time is shorter
  4. DAdminister both medicines simultaneously through the same tubing without review
Show answerCorrect answer: A

Physical or chemical incompatibility can cause precipitation, loss of potency, or catheter problems. Administration should use a separate lumen when available or an institutionally approved procedure that addresses infusion interruption and line flushing.

Question 7

A newborn born at 30 weeks' gestation is receiving a renally eliminated medicine. Compared with a term newborn of the same postnatal age, which consideration is generally most important when estimating renal drug clearance?

  1. AThe preterm infant may have lower renal clearance because kidney function is less mature
  2. BThe preterm infant necessarily has higher renal clearance because of lower body weight
  3. CRenal clearance is independent of gestational age after birth
  4. DThe preterm infant should always receive the adult dose adjusted only for weight
Show answerCorrect answer: A

Renal function develops with gestational and postnatal maturation. A preterm infant may clear renally eliminated drugs more slowly than a term newborn, so drug-specific neonatal dosing guidance and monitoring are important.

How to use this practice test

Access is free. A session presents up to 20 random questions from the 50-question BCPPS practice bank; submit your answers to see results. Use missed items to identify whether the gap involved dose calculation, developmental pharmacokinetics, adverse-effect recognition, or a medication-safety decision, then revisit that specific concept.

Preparation tips

  • For weight-based calculations, convert units carefully, calculate the dose per administration, and compare it with the stated adult maximum before finalizing the amount.
  • Practice converting a prescribed dose in milligrams into a liquid volume using the product concentration, while keeping dose and concentration units consistent.
  • Compare renal drug-clearance considerations across newborns and older children; account for gestational age and postnatal development when interpreting neonatal scenarios.
  • For medication-safety cases, check route restrictions, infusion compatibility, renal status, QT-risk information, and relevant adverse effects before deciding on an action.
  • Review how insulin therapy in diabetic ketoacidosis changes as glucose and acidosis improve, including the need to interpret treatment response rather than glucose alone.
Official sourceOfficial exam page ↗Official exam guide ↗